SCHEMBL7049684

SCHEMBL7049684

NCCC(Oc1ccc(Cl)cc1)c1ccccc1

nearest known ligand 0.66

Predicted protein targets (top 14)

geneUniProtsupporting neighboursconfidence
SLC6A4 P31645 5/20 0.66
SLC6A2 P23975 4/20 0.66
SLC6A3 Q01959 2/20 0.66
KCNK2 O95069 1/20 0.66
KCNH2 Q12809 1/20 0.66
CACNA1C Q13936 1/20 0.66
NOS2 P35228 3/20 0.57
CYP2D6 P10635 2/20 0.57
SLC7A5 Q01650 7/20 0.54
SLC6A9 P48067 1/20 0.52
CHRNB2 P17787 1/20 0.50
CHRNA4 P43681 1/20 0.50
HTR1A P08908 1/20 0.50
SCN4A P35499 1/20 0.49

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Oxalic Acid SCHEMBL7318674 0.93 SLC6A4 (0.61) SLC6A4SLC6A2SLC6A3KCNK2KCNH2
SCHEMBL17278127 0.89 SLC7A5 (0.68) SLC6A4SLC6A2SLC6A3KCNK2KCNH2
SCHEMBL1045800 0.88 SLC6A4 (0.71) SLC6A4SLC6A2SLC6A3KCNK2KCNH2
SCHEMBL18960366 0.86 NOS2 (0.62) SLC6A4SLC6A2SLC6A3KCNK2KCNH2
SCHEMBL5398425 0.83 SLC6A4 (0.66) SLC6A4SLC6A2SLC6A3KCNK2KCNH2
SCHEMBL7056008 0.83 SLC6A4 (0.66) SLC6A4SLC6A2SLC6A3KCNK2KCNH2
SCHEMBL684955 0.83 SLC6A4 (0.66) SLC6A4SLC6A2SLC6A3KCNK2KCNH2
SCHEMBL7053112 0.83 SLC6A4 (0.70) SLC6A4SLC6A2SLC6A3KCNK2KCNH2
SCHEMBL5405168 0.83 SLC6A4 (0.66) SLC6A4SLC6A2SLC6A3KCNK2KCNH2
SCHEMBL14415641 0.83 SLC6A4 (0.57) SLC6A4SLC6A2SLC6A3KCNK2KCNH2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0831799-B1 COMPOUNDS ACTIVE AT A NOVEL SITE ON RECEPTOR-OPERATED CALCIUM CHANNELS USEFUL FOR TREATMENT OF NEUROLOGICAL DISORDERS NPS PHARMA INC (US) 2003-05-02 EP claimed
EP-0831799-B1 COMPOUNDS ACTIVE AT A NOVEL SITE ON RECEPTOR-OPERATED CALCIUM CHANNELS USEFUL FOR TREATMENT OF NEUROLOGICAL DISORDERS NPS PHARMA INC (US) 2003-05-02 EP disclosed